125 related articles for article (PubMed ID: 6687575)
1. [The effects of plasma exchange upon patients with malignant exophthalmos due to Graves' disease].
Fukino O; Tamai H; Kimura T; Nakagawa T; Inaba S; Kuma K; Kubota K; Kuzuya N; Uchimura H; Nagataki S
Nihon Naibunpi Gakkai Zasshi; 1983 Jan; 59(1):72-80. PubMed ID: 6687575
[No Abstract] [Full Text] [Related]
2. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Sawhney RC; Kannan V; Rastogi GK
J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
[No Abstract] [Full Text] [Related]
3. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
[No Abstract] [Full Text] [Related]
4. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
Chopra IJ; Chopra U; Orgiazzi J
J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
[No Abstract] [Full Text] [Related]
6. Thyroid gland in Graves' disease: victim or culprit?
Chopra IJ; Solomon DH; Johnson DE; Chopra U
Metabolism; 1970 Oct; 19(10):760-72. PubMed ID: 5535910
[No Abstract] [Full Text] [Related]
7. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
8. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
9. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
10. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
McKenzie JM; Zakarija M; D'Amour P; Joasoo A
N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
[No Abstract] [Full Text] [Related]
11. [Determination of serum thyroid-stimulating immunoglobulin and its clinical significance in patients with Graves' disease].
Leng S
Zhonghua Yi Xue Za Zhi; 1984 Apr; 64(4):200-2. PubMed ID: 6147186
[No Abstract] [Full Text] [Related]
12. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.
Pittman JG; Maloof F
Am J Med Sci; 1972 Dec; 264(6):499-505. PubMed ID: 4119609
[No Abstract] [Full Text] [Related]
13. Long-acting thyroid stimulator in Graves' disease.
Sellers EA; Awad AG; Schönbaum E
Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
[No Abstract] [Full Text] [Related]
14. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
15. Serum immunoglobulin G4 levels and Graves' disease phenotype.
Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
[TBL] [Abstract][Full Text] [Related]
16. [Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].
Földes J; Gesztesi E; Takács I
Klin Wochenschr; 1971 May; 49(9):554-7. PubMed ID: 4102376
[No Abstract] [Full Text] [Related]
17. [Familial Basedow's disease in 3 generations].
Gilbert-Dreyfus ; Peillon F; Doucet D
Ann Med Interne (Paris); 1972 Nov; 123(11):937-40. PubMed ID: 4679054
[No Abstract] [Full Text] [Related]
18. Relationships among immunoglobulin markers in Graves' disease.
Ozawa Y; Maciel RM; Chopra IJ; Solomon DH; Beall GN
J Clin Endocrinol Metab; 1979 Mar; 48(3):381-7. PubMed ID: 581874
[No Abstract] [Full Text] [Related]
19. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
Hyman BN; Johnson PC
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
[No Abstract] [Full Text] [Related]
20. Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism.
Kourides IA; Pekonen F; Weintraub BD
J Clin Endocrinol Metab; 1980 Aug; 51(2):272-4. PubMed ID: 6105164
[No Abstract] [Full Text] [Related]
[Next] [New Search]